S&S Healthcare Holding Ltd. (TPEX:4198)
41.20
+0.30 (0.73%)
Aug 26, 2026, 12:14 PM CST
S&S Healthcare Holding Revenue
S&S Healthcare Holding had revenue of 32.66M TWD in the quarter ending June 30, 2026, a decrease of -14.53%. This brings the company's revenue in the last twelve months to 172.45M, down -22.17% year-over-year. In the year 2025, S&S Healthcare Holding had annual revenue of 204.21M, down -15.00%.
Revenue (ttm)
172.45M
Revenue Growth
-22.17%
P/S Ratio
5.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
986.02M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 204.21M | -36.04M | -15.00% |
| Dec 31, 2024 | 240.25M | -14.28M | -5.61% |
| Dec 31, 2023 | 254.52M | 86.00K | 0.03% |
| Dec 31, 2022 | 254.44M | 132.08M | 107.95% |
| Dec 31, 2021 | 122.35M | 20.99M | 20.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| AViTA | 972.61M |
| Bioptik Technology Incorporation | 912.86M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 409.16M |
| Wiltrom | 314.09M |
| Taiwan Biomaterial | 182.32M |